The Stony Brook Neurosciences Institute is set to host the Meeting of the Minds Symposium, titled “A Spotlight on Neuromodulation,” on January 9, 2026. The event will take place at the Charles B. Wang Center Theater and aims to highlight interdisciplinary achievements in neuromodulation.
The symposium will feature presentations from leading researchers and clinicians who will discuss recent advances in research and clinical care within the neurosciences. Nicola G. Cascella, MD, from Johns Hopkins University School of Medicine, will deliver the keynote address on deep brain stimulation in treatment-resistant schizophrenia.
Faculty members from the Renaissance School of Medicine at Stony Brook University are scheduled to present their work as well. Joshua Plotkin will discuss how dysregulated acetylcholine can drive OCD-like behaviors. Chuck Mikell, MD, and Sima Mofakham will speak about restoring mind and meaning through neuromodulation. Stephen Post will address questions about the significance of the brain from a medical humanities perspective.
Chad Bouton from the Feinstein Institutes for Medical Research at Northwell Health is also slated to present on advancements in brain-body interfaces and artificial intelligence.
Following these talks, attendees can participate in a Q&A session and a luncheon that includes local neuroimaging projects and poster presentations.
“The symposium brings together leading researchers and clinicians to present the latest research advances and clinical care in a specific field of interest within the neurosciences. This year’s focus will showcase current interdisciplinary achievements in the field of neuromodulation.”
The event is open to physicians, healthcare professionals, researchers, students, and anyone interested in neuromodulation. Complimentary breakfast and lunch will be provided. Registration is available online through the Stony Brook Neurosciences Institute website.
